Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Ther ; 15(6): 1041-50, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8111801

RESUMO

Thirty-nine patients with diabetes and hypertension were treated with indapamide for 24 weeks to study the effects of that drug on glucose and lipid metabolism. The drug was administered at a dose of 2 mg once per day in the morning as a single drug (26 patients) or in combination with other antihypertensive drugs (13 patients), including calcium antagonists, angiotensin-converting enzyme inhibitors, an alpha-blocker, or a beta-blocker. Blood pressure was reduced in both groups during treatment, and no alteration of glycemic control or lipid metabolism was observed. One patient complained of a mild headache, but treatment was continued. The results indicate that indapamide is useful for the long-term treatment of hypertension in diabetic patients, either alone or in combination with other antihypertensive agents.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Tipo 2/complicações , Hipertensão/tratamento farmacológico , Indapamida/uso terapêutico , Lipídeos/sangue , Idoso , Anti-Hipertensivos/administração & dosagem , Anti-Hipertensivos/uso terapêutico , Colesterol/sangue , Diabetes Mellitus Tipo 2/sangue , Quimioterapia Combinada , Jejum/metabolismo , Feminino , Hemoglobinas Glicadas/análise , Humanos , Hipertensão/sangue , Hipertensão/complicações , Indapamida/administração & dosagem , Lipoproteínas HDL/sangue , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...